Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report

被引：2
|
作者：
Kim, Jin Hae [1 ]
Kim, Ji Won [1 ]
Kim, Young Nam [1 ]
Kim, Hye In [1 ]
Kim, Jun Young [1 ]
Kwon, Ghee Young [3 ]
Kim, Kihyun [4 ]
Jang, Hye Ryoun [2 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Nephrol, 81 Irwon Ro, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pathol, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, Seoul, South Korea
来源：
CASE REPORTS IN NEPHROLOGY AND DIALYSIS | 2015年 / 5卷 / 03期
关键词：
Multiple myeloma; Monoclonal gammopathy of undetermined significance; Proteinuria;
D O I：
10.1159/000439267
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Monoclonal gammopathy with undetermined significance (MGUS) carries a risk of progression to multiple myeloma, and progression is usually diagnosed with changes in M-protein or bone marrow biopsy. We report a case of 62-year-old female patient showing MGUS progression to multiple myeloma without significant changes in M-protein but diagnosed by kidney biopsy. During the follow-ups, azotemia and tubular proteinuria were aggravated without elevation of M-protein. Kidney biopsy showed intratubular and glomerular inclusions associated with plasma cell dysplasia. The progression of MGUS to multiple myeloma was diagnosed by this kidney biopsy. The patient's renal function and tubular proteinuria were markedly improved after chemotherapy. (C) 2015 S. Karger AG, Basel
引用
收藏
页码：180 / 186
页数：7
相关论文
共 50 条
  • [1] Pathogenesis of Monoclonal Gammopathy of Undetermined Significance and Progression to Multiple Myeloma
    Zingone, Adriana
    Kuehl, W. Michael
    SEMINARS IN HEMATOLOGY, 2011, 48 (01) : 4 - 12
  • [2] Monoclonal gammopathy of undetermined significance and multiple myeloma
    Schmalzing, M.
    Tony, H. -P.
    Knop, S.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 : 33 - 37
  • [3] Case Study on Monoclonal Gammopathy of Undetermined Significance/Multiple Myeloma
    Cappellini, Maria Domenica
    CLINICAL THERAPEUTICS, 2009, 31 : S181 - S181
  • [4] Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    JAMA ONCOLOGY, 2015, 1 (02) : 174 - 175
  • [5] Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in a Solid Organ Transplant
    Redfield, Robert R.
    Naji, Ali
    TRANSPLANTATION, 2011, 92 (12) : E65 - E66
  • [6] Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma
    Mailankody, Sham
    Mena, Esther
    Yuan, Constance M.
    Balakumaran, Arun
    Kuehl, W. Michael
    Landgren, Ola
    LEUKEMIA & LYMPHOMA, 2010, 51 (12) : 2159 - 2170
  • [7] Monoclonal Gammopathy of undetermined significance and smoldering multiple myeloma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (06) : 1093 - +
  • [8] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Robert A. Kyle
    S. Vincent Rajkumar
    Current Hematologic Malignancy Reports, 2010, 5 : 62 - 69
  • [9] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Kyle, Robert A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Rajkumar, S. Vincent
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 775 - +
  • [10] Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance
    Bladé J.
    Rosiñol L.
    Current Treatment Options in Oncology, 2006, 7 (3) : 237 - 245
12345